Sekundäre Hyperlipoproteinämien: Es ist nicht immer so, wie es scheint
Waldmann-Roth, E.; Parhofer, K.-G. · MMW - Fortschritte der Medizin · 2025 · Heft 6 · S. 56 bis 59
Bibliografische Angaben
Zusammenfassung
Cardiovascular diseases are the leading cause of death in Germany and most developed countries. Elevated lipid levels are causally linked to the development and progression of atherosclerotic disease. Although primary dyslipidemias are common, it is necessary to rule out secondary causes, especially hypothyroidism, (chronic or acute) kidney disease, diabetes mellitus and liver disease. In addition, some newly developed therapeutics e.g. in oncology may also cause hyper- or dyslipoproteinemia. In such cases the primary goal is to treat the underlying causes and only use specific lipid lowering therapies if second…